ecancer is a charity with a mission to raise the standards of care for cancer patients across the world through education. #openaccess
Joined February 2009
- Tweets 21,885
- Following 4,446
- Followers 17,109
- Likes 6,339
4,897 Photos and videos
Broadcasting live in 1 hour, tune in to our free webinar.....ecancer.org/bcqualitycare #breastcancer #surgery #healthpolicy
73
ecancer retweeted
Jun 10
Happy to see more than 1000 views on this @ecancer video of #ASCO26 highlights from @oncology_bg within one week of the ASCO meeting being over. This is truly your Best of ASCO in 40 mins.
ecancer.org/en/video/12984-a…
2
1
300
ecancer retweeted
Last week, we had 4 videos come out.
1. Highlights from #ASCO26 @ecancer: ecancer.org/en/video/12984-a…
2. On draxonrasib, the new pancreatic cancer drug trial, for @CBCTheNational : cbc.ca/news/health/experimen…
youtu.be/D0s3SU_S6Gk?si=4ZFT…
3. On interpreting clinical trials @MedscapeOnc
medscape.com/viewarticle/tox…
4. On 5 fallacies in Medicine @Medscape
medscape.com/viewarticle/fac…
2
2
13
1,325
ecancer retweeted
Jun 8
Last week, we had 4 videos come out.
1. Highlights from #ASCO26 @ecancer: ecancer.org/en/video/12984-a…
2. On draxonrasib, the new pancreatic cancer drug trial, for @CBCTheNational : cbc.ca/news/health/experimen…
youtu.be/D0s3SU_S6Gk?si=4ZFT…
3. On interpreting clinical trials @MedscapeOnc
medscape.com/viewarticle/tox…
4. On 5 fallacies in Medicine @Medscape
medscape.com/viewarticle/fac…
1
3
175
ecancer retweeted
Jun 5
New paper published in @ecancer on travel burden for patients with colorectal cancer in Kashmir, India. ecancer.org/en/journal/artic…
The first author of this paper is Dr. Saquib Banday who was paired with @oncology_bg for 2022 @myESMO virtual mentorship program.
1
5
6
1,036
ecancer retweeted
New #openaccess paper published in @ecancer ! ecancer.org/en/journal/artic…
Led by Dr. Saquib Banday, my mentee from the @myESMO 2022 Virtual Mentorship Program, we look at travel burden among patients with colorectal cancer in the resource limited settings of Kashmir, India. We find that - in very simplified terms- living farther away from cancer center is associated with worse outcomes unless you’re rich enough to rent an apartment nearby.
1
8
25
3,966
ecancer retweeted
Honored to discuss key messages perioperative #PROTEUS data and the precision-medicine signal from #TALAPRO-3 in HRR-altered mHSPC @ecancer @OncoAlert @EfstathiouEleni @ProfHadaschik @urotoday
ecancer.org/en/video/12975-a…
2
7
11
627
ecancer retweeted
Hey everyone, want to catchup on the latest highlights from #ASCO26 ? I cover all plenary trials and other important studies.
My @ecancer highlights video is now up! Check it out.
ecancer.org/en/video/12984-a…
8
21
2,259
ecancer retweeted
Hey it’s out! The thing that you’ve been waiting for is out!
BG’s @ecancer #ASCO26 highlights video is now live.
Watch for a bias-free commentary on the most important takeaways from this year’s @ASCO meeting. ecancer.org/en/video/12984-a…
1
8
21
4,752
At #ASCO26, Dr Marchetti @clamarchetti81 presented findings showing that short-term fasting improved chemotherapy response and prolonged progression-free survival in advanced #ovariancancer. Watch the interview now ▶️ecancer.org/en/video/12978-s…
1
131
Can radiotherapy be safely reduced for selected patients with HPV-associated #oropharyngealcancer? At #ASCO26, Dr @imrtlee indicates that FMISO PET-guided radiation de-escalation maintained excellent outcomes while reducing treatment intensity for most. ecancer.org/en/video/12977-f…
122
Could tarlatamab improve outcomes for patients with #smallcelllungcancer and #brainmetastases? At #ASCO26, Dr Mountzios reviews data showing improved intracranial PFS, OS, and brain response rates with tarlatamab compared with chemotherapy. @g_mountzios ecancer.org/en/video/12959-t…
115
ecancer retweeted
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
92
1,273
6,505
1,148,714
New data presented at #ASCO26 by Dr McDonald suggests that GLP-1 therapies may be linked to a lower incidence of #BreastCancer in women. Watch the interview now 👇ecancer.org/en/video/12973-g…
2
2
533
Why are younger adults with #GastrointestinalCancers experiencing worse outcomes? At #ASCO26, Dr Paulus from @OntadaOncology highlights higher rates of advanced-stage disease and significant racial disparities among patients diagnosed before age 50. ecancer.org/en/video/12961-e…
1
83
New data in metastatic uveal #melanoma at #ASCO26 suggest that darovasertib crizotinib may offer a new treatment option for patients with limited alternatives. Dr Orloff of @TJUHospital highlights improved PFS and response rates vs standard therapy. ecancer.org/en/video/12963-d…
112
Could aspirin have a role in #endometrialcancer treatment? At #ASCO26, Dr Gentry reviews data suggesting that aspirin use at diagnosis was associated with improved disease-specific survival in patients with endometrial cancer. Watch the interview now: ecancer.org/en/video/12955-a…
1
84
Could a blood-based biomarker improve relapse detection in germ cell tumours? At #ASCO26, Dr
@LuciaNappi4 highlights data showing that circulating miR371 accurately detected recurrence in patients on active surveillance. Watch now 👇ecancer.org/en/video/12954-m…
3
3
184
7 years on, lorlatinib continues to deliver durable disease control in ALK-positive #NSCLC. At #ASCO26, Prof @TonyMok9 reviews data showing sustained PFS and intracranial protection, reinforcing lorlatinib as a highly effective first-line treatment option. ecancer.org/en/video/12950-l…
163
Real-world data presented at #ASCO26 by Dr Paulus from @OntadaOncology suggests that GLP-1 therapies may be linked to improved OS in cancer pts. Findings support further research into potential impact of GLP-1 agonists on cancer outcomes. ecancer.org/en/video/12964-g…
1
134